Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Viral Hepatitis Endemicity and Trends among an Asymptomatic Adult Population in Ho: A 5-Year Retrospective Study at the Ho Municipal Hospital, Ghana.

Lokpo SY, Osei-Yeboah J, Norgbe GK, Owiafe PK, Ayroe F, Ussher FA, Dakorah MP, Gameli Deku J, Manaphraim NYB, Akomanin Asiamah E, Ntoni T, Senyo Kwasi Nyamadi P, Yiadom Boakye E, Avorkliyah R.

Hepat Res Treat. 2017;2017:6174743. doi: 10.1155/2017/6174743. Epub 2017 Nov 6.

2.

Hepatitis B Vaccination Status among Health Care Workers in a Tertiary Hospital in Ethiopia.

Biset Ayalew M, Adugna Horsa B.

Hepat Res Treat. 2017;2017:6470658. doi: 10.1155/2017/6470658. Epub 2017 Jun 29.

3.

Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir.

Tamai H, Ida Y, Shingaki N, Shimizu R, Fukatsu K, Itonaga M, Yoshida T, Maeda Y, Moribata K, Maekita T, Iguchi M, Kato J, Kitano M.

Hepat Res Treat. 2017;2017:2093847. doi: 10.1155/2017/2093847. Epub 2017 Apr 11.

4.

Prevalence of Hepatitis B Virus Infection among Pregnant Women Attending Antenatal Clinics in Vientiane, Laos, 2008-2014.

Choisy M, Keomalaphet S, Xaydalasouk K, Quet F, Latthaphasavang V, Buisson Y.

Hepat Res Treat. 2017;2017:1284273. doi: 10.1155/2017/1284273. Epub 2017 Mar 29.

5.

Assessment of Immunization to Hepatitis B Vaccine among Children under Five Years in Rural Areas of Taiz, Yemen.

Alssamei FA, Al-Sonboli NA, Alkumaim FA, Alsayaad NS, Al-Ahdal MS, Higazi TB, Elagib AA.

Hepat Res Treat. 2017;2017:2131627. doi: 10.1155/2017/2131627. Epub 2017 Mar 6.

6.

Combinations of siRNAs against La Autoantigen with NS5B or hVAP-A Have Additive Effect on Inhibition of HCV Replication.

Mandal A, Ganta KK, Chaubey B.

Hepat Res Treat. 2016;2016:9671031. doi: 10.1155/2016/9671031. Epub 2016 Jun 29.

7.

Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy.

Klein F, Neuhaus R, Eurich D, Hofmann J, Bayraktar S, Pratschke J, Bahra M.

Hepat Res Treat. 2016;2016:8325467. doi: 10.1155/2016/8325467. Epub 2016 Apr 18.

8.

A Novel Structurally Stable Multiepitope Protein for Detection of HCV.

Galdino AS, Santos JC, Souza MQ, Nóbrega YK, Xavier MA, Felipe MS, Freitas SM, Torres FA.

Hepat Res Treat. 2016;2016:6592143. doi: 10.1155/2016/6592143. Epub 2016 Jan 28.

9.

Seroprevalence and Predictors of Hepatitis B Virus Infection among Pregnant Women Attending Routine Antenatal Care in Arba Minch Hospital, South Ethiopia.

Yohanes T, Zerdo Z, Chufamo N.

Hepat Res Treat. 2016;2016:9290163. doi: 10.1155/2016/9290163. Epub 2016 Jan 24.

10.

Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus.

Voulgaris T, Sevastianos VA.

Hepat Res Treat. 2016;2016:7629318. doi: 10.1155/2016/7629318. Epub 2016 Jan 13. Review.

11.

Prevalence of Hepatitis E Virus among Adults in South-West of Iran.

Farshadpour F, Taherkhani R, Makvandi M.

Hepat Res Treat. 2015;2015:759589. doi: 10.1155/2015/759589. Epub 2015 Jun 23.

12.

Interleukin-16 gene polymorphisms are considerable host genetic factors for patients' susceptibility to chronic hepatitis B infection.

Romani S, Hosseini SM, Mohebbi SR, Kazemian S, Derakhshani S, Khanyaghma M, Azimzadeh P, Sharifian A, Zali MR.

Hepat Res Treat. 2014;2014:790753. doi: 10.1155/2014/790753. Epub 2014 Nov 26.

13.

Knowledge of Hepatitis B Virus Infection, Immunization with Hepatitis B Vaccine, Risk Perception, and Challenges to Control Hepatitis among Hospital Workers in a Nigerian Tertiary Hospital.

Adekanle O, Ndububa DA, Olowookere SA, Ijarotimi O, Ijadunola KT.

Hepat Res Treat. 2015;2015:439867. doi: 10.1155/2015/439867. Epub 2015 Jan 22.

14.

Hepatitis B Awareness among Medical Students and Their Vaccination Status at Syrian Private University.

Ibrahim N, Idris A.

Hepat Res Treat. 2014;2014:131920. doi: 10.1155/2014/131920. Epub 2014 Nov 12.

15.

Portraying persons who inject drugs recently infected with hepatitis C accessing antiviral treatment: a cluster analysis.

Bamvita JM, Roy E, Zang G, Jutras-Aswad D, Artenie AA, Levesque A, Bruneau J.

Hepat Res Treat. 2014;2014:631481. doi: 10.1155/2014/631481. Epub 2014 Oct 1.

16.

High dose of Lamivudine and resistance in patients with chronic hepatitis B.

Wani HU, Al Kaabi S, Sharma M, Singh R, John A, Derbala M, Al-Mohannadi MJ.

Hepat Res Treat. 2014;2014:615621. doi: 10.1155/2014/615621. Epub 2014 Sep 30.

17.

Prediction of Sustained Virological Response to Telaprevir-Based Triple Therapy Using Viral Response within 2 Weeks.

Tamai H, Shimizu R, Shingaki N, Mori Y, Maeshima S, Nuta J, Maeda Y, Moribata K, Muraki Y, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.

Hepat Res Treat. 2014;2014:748935. doi: 10.1155/2014/748935. Epub 2014 Sep 28.

18.

Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia.

Sira MM, Behairy BE, Abd-Elaziz AM, Abd Elnaby SA, Eltahan EE.

Hepat Res Treat. 2014;2014:307942. doi: 10.1155/2014/307942. Epub 2014 Sep 14.

19.

Seroepidemiology of hepatitis B and C viruses in the general population of burkina faso.

Tao I, Compaoré TR, Diarra B, Djigma F, Zohoncon TM, Assih M, Ouermi D, Pietra V, Karou SD, Simpore J.

Hepat Res Treat. 2014;2014:781843. doi: 10.1155/2014/781843. Epub 2014 Aug 5.

20.

Spectrum of Histomorphologic Findings in Liver in Patients with SLE: A Review.

Grover S, Rastogi A, Singh J, Rajbongshi A, Bihari C.

Hepat Res Treat. 2014;2014:562979. doi: 10.1155/2014/562979. Epub 2014 Jul 21. Review.

Supplemental Content

Loading ...
Support Center